Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pladienolide D derivative, E-7107, shows good antitumor activity in xenografts

April 1, 2004

Bayer claims diagnostics and therapeutics for GPR19-associated diseases

April 1, 2004

Enrollment opens in phase III trial of STR in multiple myeloma

April 1, 2004

YM BioSciences to commence pivotal tesmilifene trial in coming weeks

April 1, 2004

NAD-299, RS-23597 active in prostate cancer cells

April 1, 2004

Atrasentan delays disease progression in metastatic prostate cancer

April 1, 2004

ECO-04601 demonstrates broad antitumor activity in various tumor cell lines

March 31, 2004

RGB-286199, a potent, broad-spectrum cyclin-dependent kinase inhibitor

March 31, 2004

Doxazosin reduces bladder cancer tumor growth in vivo

March 31, 2004

Enhancement of paclitaxel anticancer activity with HSP70 inducer STA-4783

March 31, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...